Unknown

Dataset Information

0

Gp-100 as a Novel Therapeutic Target in Uveal Melanoma.


ABSTRACT: Uveal melanoma is a rare neoplasm with poor prognosis in the metastatic setting. Unlike cutaneous melanoma, treatment with kinase inhibitors or immune checkpoint inhibitors is not effective. Glycoprotein 100 (Gp-100) is a protein highly expressed in melanocytes and melanoma that has recently been effectively targeted by tebentafusp, a first-in-class bispecific protein of the immune-mobilizing monoclonal T cell receptors against cancer (ImmTACs) family. Tebentafusp targets tumor cells that express a peptide of Gp-100 presented by HLA*A0201, creating an immune synapse that kills targeted tumor cells. Recently, a randomized phase III trial reported an overall survival benefit for tebentafusp in patients with untreated metastatic uveal melanoma. The aim of this comprehensive review is to summarize evidence of Gp-100 as a therapeutic target in melanoma, and the preclinical and clinical development of tebentafusp as a novel therapeutic strategy for patients with uveal melanoma.

SUBMITTER: Martinez-Perez D 

PROVIDER: S-EPMC8656894 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gp-100 as a Novel Therapeutic Target in Uveal Melanoma.

Martinez-Perez Daniel D   Viñal David D   Solares Isabel I   Espinosa Enrique E   Feliu Jaime J  

Cancers 20211127 23


Uveal melanoma is a rare neoplasm with poor prognosis in the metastatic setting. Unlike cutaneous melanoma, treatment with kinase inhibitors or immune checkpoint inhibitors is not effective. Glycoprotein 100 (Gp-100) is a protein highly expressed in melanocytes and melanoma that has recently been effectively targeted by tebentafusp, a first-in-class bispecific protein of the immune-mobilizing monoclonal T cell receptors against cancer (ImmTACs) family. Tebentafusp targets tumor cells that expres  ...[more]

Similar Datasets

| S-EPMC7755667 | biostudies-literature
| S-EPMC7835875 | biostudies-literature
| S-EPMC9582331 | biostudies-literature
| S-EPMC5528590 | biostudies-literature
| S-EPMC4876283 | biostudies-literature
| S-EPMC6769470 | biostudies-literature
| S-EPMC5342016 | biostudies-literature
| S-EPMC10419210 | biostudies-literature
| S-EPMC7589184 | biostudies-literature
| S-EPMC4418029 | biostudies-literature